Management of an acute ischemic stroke is multifaceted. Treatment in a spec
ialized stroke unit reduces mortality and morbidity. Components of care inc
lude interventions to control or prevent medical or neurologic complication
s, rehabilitation, and initiations of therapies to forestall recurrent stro
ke. The key to modern treatment is the emergent administration of tissue pl
asminogen activator (rtPA). Thrombocyte treatment improves outcome when it
is given within 3 hours of onset of stroke to carefully selected patients.